Wolverine Trading, LLC Tyme Technologies, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.28 - $0.68 $1,316 - $3,196
-4,700 Reduced 30.92%
10,500 $4,000
Q4 2021

Feb 14, 2022
BUY
$0.6 - $1.04 $780 - $1,352
1,300 Added 9.35%
15,200 $9,000
Q3 2021

Nov 12, 2021
BUY
$0.99 - $1.38 $13,761 - $19,182
13,900 New
13,900 $14,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email